Immunofluorescence Assay Market 2025 by Types, Application, Technology, Opportunities, End Users and Regions | The Insight Partners

Immunofluorescence Assay Market to 2025 - Global Analysis and Forecasts By Type (Micro Immunofluorescence, Indirect Immunofluorescence and Direct Immunofluorescence) By Product (Antibodies, Kits and reagents, Labeling dyes and instruments) By Disease (Cancer, Infectious Diseases, Cardiovascular Diseases, Autoimmune Diseases and Other Diseases) By End User( Pharmaceutical & Biotechnology Companies, Academic & Research Institutes, Hospitals & Diagnostic Centers and Contract Research Organizations)

Report Code: TIPBT00002378 | No. of Pages: 150 | Category: Biotechnology | Status: Upcoming
Immunofluorescence is a technique used for light microscopy with a fluorescence microscope and is used primarily on microbiological samples. This technique uses the specificity of antibodies to their antigen to target fluorescent dyes to specific biomolecule targets within a cell, and therefore allows visualization of the distribution of the target molecule through the sample. The specific region an antibody recognizes on an antigen is called an epitope.

The market of immunofluorescence assay is anticipated to grow with a significant rate in the coming years, owing to factors such as, increasing prevalence of chronic diseases, increasing R&D spending and growing healthcare spending.

The "Global Immunofluorescence assay Market Analysis to 2025" is a specialized and in-depth study of the medical device industry with a focus on the global market trend. The report aims to provide an overview of global immunofluorescence assay market with detailed market segmentation by type, product, disease and end user. The global immunofluorescence assay market is expected to witness high growth during the forecast period. The report provides key statistics on the market status of the leading market players and offers key trends and opportunities in the market.

The global immunofluorescence assay market is segmented on the basis of type, product, disease and end user. The type segment includes, micro immunofluorescence, indirect immunofluorescence and direct immunofluorescence. Based on product, the market is segmented as, antibodies, kits and reagents, labeling dyes and instruments. The segment of disease classified into cancer, infectious diseases, cardiovascular diseases, autoimmune diseases and other diseases. Based on end user, the market is segmented as, pharmaceutical & biotechnology companies, academic & research institutes, hospitals & diagnostic centers and contract research organizations.

The report provides a detailed overview of the industry including both qualitative and quantitative information. It provides overview and forecast of the global immunofluorescence assay market based on type, product, disease and end user. It also provides market size and forecast till 2025 for overall Immunofluorescence assay market with respect to five major regions, namely; North America, Europe, Asia-Pacific (APAC), Middle East and Africa (MEA) and South & Central America. The market by each region is later sub-segmented by respective countries and segments. The report covers analysis and forecast of 13 countries globally along with current trend and opportunities prevailing in the region.

North America is expected to contribute to the largest share in the immunofluorescence assay market in the coming years, the rising incidence of lifestyle diseases, increasing R&D spending, robust research activities, favorable government funding opportunities, and the presence of major market players in the region. Asia Pacific is expected to witness significant growth rate during the forecast period primarily due to the large patient population, high incidence of infectious diseases, developing healthcare infrastructure and growing biotechnology sector influences the market in this region. Also, the presence of emerging economies like China, India, and Japan drive the market growth.

The report analyzes factors affecting market from both demand and supply side and further evaluates market dynamics effecting the market during the forecast period i.e., drivers, restraints, opportunities, and future trend. The report also provides exhaustive PEST analysis for all five regions namely; North America, Europe, APAC, MEA and South & Central America after evaluating political, economic, social and technological factors effecting the market in these regions.

The report also includes the profiles of key immunofluorescence assay companies along with their SWOT analysis and market strategies. In addition, the report focuses on leading industry players with information such as company profiles, products and services offered, financial information of last 3 years, key development in past five years. Some of the key players influencing the market are Thermo Fisher Scientific Inc., Abcam PLC, Bio-Rad Laboratories, Inc., Perkinelmer Inc., Merck KGaA, Becton Dickinson and Company, Agilent Technologies, Enzo Life Sciences, Inc., Sino Biological Inc., and Danaher.
Table of Contents

1. INTRODUCTION
1.1. SCOPE OF STUDY
1.2. THE INSIGHT PARTNERS RESEARCH REPORT GUIDANCE

2. KEY TAKEAWAYS

3. IMMUNOFLUORESCENCE ASSAY MARKET LANDSCAPE
3.1. MARKET OVERVIEW
3.2. MARKET SEGMENTATION
3.2.1. Immunofluorescence Assay Market - By Type
3.2.2. Immunofluorescence Assay Market - By Product
3.2.3. Immunofluorescence Assay Market - By Disease
3.2.4. Immunofluorescence Assay Market - By End User
3.2.5. Immunofluorescence Assay Market - By Region
3.2.5.1. By Country
3.3. PEST ANALYSIS
3.3.1. North America - PEST Analysis
3.3.2. Europe - PEST Analysis
3.3.3. Asia Pacific - PEST Analysis
3.3.4. Middle East and Africa - PEST Analysis
3.3.5. South and Central America- PEST Analysis

4. IMMUNOFLUORESCENCE ASSAY MARKET - KEY INDUSTRY DYNAMICS
4.1. KEY MARKET DRIVERS
4.2. KEY MARKET RESTRAINTS
4.3. KEY MARKET OPPORTUNITIES
4.4. FUTURE TRENDS
4.5. IMPACT ANALYSIS

5. IMMUNOFLUORESCENCE ASSAY MARKET - GLOBAL ANALYSIS
5.1. GLOBAL IMMUNOFLUORESCENCE ASSAY MARKET OVERVIEW
5.2. GLOBAL IMMUNOFLUORESCENCE ASSAY MARKET REVENUE FORECASTS AND ANALYSIS (US$ MN)
5.3. MARKET POSITIONING/MARKET SHARE
5.4. PERFORMANCE OF KEY PLAYERS
5.5. CLINICAL TRAILS
5.6. EXPERT OPINIONS

6. IMMUNOFLUORESCENCE ASSAY MARKET REVENUE AND FORECASTS TO 2025 - BY TYPE
6.1. OVERVIEW
6.2. TYPE MARKET REVENUE AND FORECASTS ANALYSIS (US$ MN)
6.3. MICRO IMMUNOFLUORESCENCE MARKET
6.3.1. Overview
6.3.2. Micro Immunofluorescence Market Revenue Forecasts and Analysis (US$ Mn)
6.4. INDIRECT IMMUNOFLUORESCENCE MARKET
6.4.1. Overview
6.4.2. Indirect Immunofluorescence Market Revenue Forecasts and Analysis (US$ Mn)
6.5. DIRECT IMMUNOFLUORESCENCE MARKET
6.5.1. Overview
6.5.2. Direct Immunofluorescence Market Revenue Forecasts and Analysis (US$ Mn)

7. IMMUNOFLUORESCENCE ASSAY MARKET REVENUE AND FORECASTS TO 2025 - BY PRODUCT
7.1. OVERVIEW
7.2. PRODUCT MARKET REVENUE AND FORECASTS ANALYSIS (US$ MN)
7.3. ANTIBODIES MARKET
7.3.1. Overview
7.3.2. Antibodies Market Revenue Forecasts and Analysis (US$ Mn)
7.4. KITS AND REAGENTS MARKET
7.4.1. Overview
7.4.2. Kits And Reagents Market Revenue Forecasts and Analysis (US$ Mn)
7.5. LABELING DYES MARKET
7.5.1. Overview
7.5.2. Labeling Dyes Market Revenue Forecasts and Analysis (US$ Mn)
7.6. INSTRUMENTS MARKET
7.6.1. Overview
7.6.2. Instruments Market Revenue Forecasts and Analysis (US$ Mn)

8. IMMUNOFLUORESCENCE ASSAY MARKET REVENUE AND FORECASTS TO 2025 - BY DISEASE
8.1. OVERVIEW
8.2. DISEASE MARKET REVENUE AND FORECASTS ANALYSIS (US$ MN)
8.3. CANCER MARKET
8.3.1. Overview
8.3.2. Cancer Market Revenue Forecasts and Analysis (US$ Mn)
8.4. INFECTIOUS DISEASES MARKET
8.4.1. Overview
8.4.2. Infectious Diseases Market Revenue Forecasts and Analysis (US$ Mn)
8.5. CARDIOVASCULAR DISEASES MARKET
8.5.1. Overview
8.5.2. Cardiovascular Diseases Market Revenue Forecasts and Analysis (US$ Mn)
8.6. AUTOIMMUNE DISEASES MARKET
8.6.1. Overview
8.6.2. Autoimmune Diseases Market Revenue Forecasts and Analysis (US$ Mn)
8.7. OTHER DISEASES MARKET
8.7.1. Overview
8.7.2. Other Diseases Market Revenue Forecasts and Analysis (US$ Mn)

9. IMMUNOFLUORESCENCE ASSAY MARKET REVENUE AND FORECASTS TO 2025 - BY END USER
9.1. OVERVIEW
9.2. END USER MARKET REVENUE AND FORECASTS ANALYSIS (US$ MN)
9.3. PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES MARKET
9.3.1. Overview
9.3.2. Pharmaceutical & Biotechnology Companies Market Revenue Forecasts and Analysis (US$ Mn)
9.4. CLINICAL RESEARCH ORGANIZATIONS MARKET
9.4.1. Overview
9.4.2. Clinical Research Organizations Market Revenue Forecasts and Analysis (US$ Mn)
9.5. ACADEMIC & RESEARCH INSTITUTES MARKET
9.5.1. Overview
9.5.2. Academic & Research Institutes Market Revenue Forecasts and Analysis (US$ Mn)
9.6. HOSPITALS & DIAGNOSTIC CENTERS MARKET
9.6.1. Overview
9.6.2. Hospitals & Diagnostic Centers Market Revenue Forecasts and Analysis (US$ Mn)

10. NORTH AMERICA IMMUNOFLUORESCENCE ASSAY MARKET REVENUE AND FORECASTS TO 2025 - COUNTRY ANALYSIS
10.1. NORTH AMERICA IMMUNOFLUORESCENCE ASSAY MARKET OVERVIEW
10.2. NORTH AMERICA IMMUNOFLUORESCENCE ASSAY MARKET REVENUE FORECASTS AND ANALYSIS (US$ MN)
10.3. NORTH AMERICA IMMUNOFLUORESCENCE ASSAY MARKET REVENUE AND FORECASTS ANALYSIS - BY TYPE (US$ MN)
10.4. NORTH AMERICA IMMUNOFLUORESCENCE ASSAY MARKET REVENUE AND FORECASTS ANALYSIS - BY PRODUCT (US$ MN)
10.5. NORTH AMERICA IMMUNOFLUORESCENCE ASSAY MARKET REVENUE AND FORECASTS ANALYSIS - BY DISEASE (US$ MN)
10.6. NORTH AMERICA IMMUNOFLUORESCENCE ASSAY MARKET REVENUE AND FORECASTS ANALYSIS - BY END USER (US$ MN)
10.7. NORTH AMERICA IMMUNOFLUORESCENCE ASSAY MARKET REVENUE AND FORECASTS ANALYSIS - BY COUNTRY (US$ MN)
10.8. US MARKET OVERVIEW
10.8.1. US Immunofluorescence Assay Market Revenue Forecasts and Analysis - By Type (US$ Mn)
10.8.2. US Immunofluorescence Assay Market Revenue Forecasts and Analysis - By Product (US$ Mn)
10.8.3. US Immunofluorescence Assay Market Revenue Forecasts and Analysis - By Disease (US$ Mn)
10.8.4. US Immunofluorescence Assay Market Revenue Forecasts and Analysis - By End User (US$ Mn)
10.9. CANADA MARKET OVERVIEW
10.9.1. Canada Immunofluorescence Assay Market Revenue Forecasts and Analysis - By Type (US$ Mn)
10.9.2. Canada Immunofluorescence Assay Market Revenue Forecasts and Analysis - By Product (US$ Mn)
10.9.3. Canada Immunofluorescence Assay Market Revenue Forecasts and Analysis - By Disease (US$ Mn)
10.9.4. Canada Immunofluorescence Assay Market Revenue Forecasts and Analysis - By End User (US$ Mn)
10.10. MEXICO MARKET OVERVIEW
10.10.1. Mexico Immunofluorescence Assay Market Revenue Forecasts and Analysis - By Type (US$ Mn)
10.10.2. Mexico Immunofluorescence Assay Market Revenue Forecasts and Analysis - By Product (US$ Mn)
10.10.3. Mexico Immunofluorescence Assay Market Revenue Forecasts and Analysis - By Disease (US$ Mn)
10.10.4. Mexico Immunofluorescence Assay Market Revenue Forecasts and Analysis - By End User (US$ Mn)

11. EUROPE IMMUNOFLUORESCENCE ASSAY MARKET REVENUE AND FORECASTS TO 2025 - COUNTRY ANALYSIS
11.1. EUROPE IMMUNOFLUORESCENCE ASSAY MARKET OVERVIEW
11.2. EUROPE IMMUNOFLUORESCENCE ASSAY MARKET REVENUE FORECASTS AND ANALYSIS (US$ MN)
11.3. EUROPE IMMUNOFLUORESCENCE ASSAY MARKET REVENUE AND FORECASTS ANALYSIS - BY TYPE (US$ MN)
11.4. EUROPE IMMUNOFLUORESCENCE ASSAY MARKET REVENUE AND FORECASTS ANALYSIS - BY DISEASE (US$ MN)
11.5. EUROPE IMMUNOFLUORESCENCE ASSAY MARKET REVENUE AND FORECASTS ANALYSIS - BY PRODUCT (US$ MN)
11.6. EUROPE IMMUNOFLUORESCENCE ASSAY MARKET REVENUE AND FORECASTS ANALYSIS - BY END USER (US$ MN)
11.7. EUROPE IMMUNOFLUORESCENCE ASSAY MARKET REVENUE AND FORECASTS ANALYSIS - BY COUNTRY (US$ MN)
11.8. FRANCE MARKET OVERVIEW
11.8.1. France Immunofluorescence Assay Market Revenue Forecasts and Analysis - By Type (US$ Mn)
11.8.2. France Immunofluorescence Assay Market Revenue Forecasts and Analysis - By Product (US$ Mn)
11.8.3. France Immunofluorescence Assay Market Revenue Forecasts and Analysis - By Disease (US$ Mn)
11.8.4. France Immunofluorescence Assay Market Revenue Forecasts and Analysis - By End User (US$ Mn)
11.9. GERMANY MARKET OVERVIEW
11.9.1. Germany Immunofluorescence Assay Market Revenue Forecasts and Analysis - By Type (US$ Mn)
11.9.2. Germany Immunofluorescence Assay Market Revenue Forecasts and Analysis - By Product (US$ Mn)
11.9.3. Germany Immunofluorescence Assay Market Revenue Forecasts and Analysis - By Disease (US$ Mn)
11.9.4. Germany Immunofluorescence Assay Market Revenue Forecasts and Analysis - By End User (US$ Mn)
11.10. UK MARKET OVERVIEW
11.10.1. UK Immunofluorescence Assay Market Revenue Forecasts and Analysis - By Type (US$ Mn)
11.10.2. UK Immunofluorescence Assay Market Revenue Forecasts and Analysis - By Product (US$ Mn)
11.10.3. UK Immunofluorescence Assay Market Revenue Forecasts and Analysis - By Disease (US$ Mn)
11.10.4. UK Immunofluorescence Assay Market Revenue Forecasts and Analysis - By End User (US$ Mn)
12. ASIA PACIFIC IMMUNOFLUORESCENCE ASSAY MARKET REVENUE AND FORECASTS TO 2025 - COUNTRY ANALYSIS
12.1. ASIA PACIFIC IMMUNOFLUORESCENCE ASSAY MARKET OVERVIEW
12.2. ASIA PACIFIC IMMUNOFLUORESCENCE ASSAY MARKET REVENUE FORECASTS AND ANALYSIS (US$ MN)
12.3. ASIA PACIFIC IMMUNOFLUORESCENCE ASSAY MARKET REVENUE AND FORECASTS ANALYSIS - BY TYPE (US$ MN)
12.4. ASIA PACIFIC IMMUNOFLUORESCENCE ASSAY MARKET REVENUE AND FORECASTS ANALYSIS - BY PRODUCT (US$ MN)
12.5. ASIA PACIFIC IMMUNOFLUORESCENCE ASSAY MARKET REVENUE AND FORECASTS ANALYSIS - BY DISEASE (US$ MN)
12.6. ASIA PACIFIC IMMUNOFLUORESCENCE ASSAY MARKET REVENUE AND FORECASTS ANALYSIS - BY END USER (US$ MN)
12.7. ASIA PACIFIC IMMUNOFLUORESCENCE ASSAY MARKET REVENUE AND FORECASTS ANALYSIS - BY COUNTRY (US$ MN)
12.8. CHINA MARKET OVERVIEW
12.8.1. China Immunofluorescence Assay Market Revenue Forecasts and Analysis - By Type (US$ Mn)
12.8.2. China Immunofluorescence Assay Market Revenue Forecasts and Analysis - By Product (US$ Mn)
12.8.3. China Immunofluorescence Assay Market Revenue Forecasts and Analysis - By Disease (US$ Mn)
12.8.4. China Immunofluorescence Assay Market Revenue Forecasts and Analysis - By End User (US$ Mn)
12.9. INDIA MARKET OVERVIEW
12.9.1. India Immunofluorescence Assay Market Revenue Forecasts and Analysis - By Type (US$ Mn)
12.9.2. India Immunofluorescence Assay Market Revenue Forecasts and Analysis - By Product (US$ Mn)
12.9.3. India Immunofluorescence Assay Market Revenue Forecasts and Analysis - By Disease (US$ Mn)
12.9.4. India Immunofluorescence Assay Market Revenue Forecasts and Analysis - By End User (US$ Mn)
12.10. JAPAN MARKET OVERVIEW
12.10.1. Japan Immunofluorescence Assay Market Revenue Forecasts and Analysis - By Type (US$ Mn)
12.10.2. Japan Immunofluorescence Assay Market Revenue Forecasts and Analysis - By Product (US$ Mn)
12.10.3. Japan Immunofluorescence Assay Market Revenue Forecasts and Analysis - By Disease (US$ Mn)
12.10.4. Japan Immunofluorescence Assay Market Revenue Forecasts and Analysis - By End User (US$ Mn)

13. MIDDLE EAST AND AFRICA (MEA) IMMUNOFLUORESCENCE ASSAY MARKET REVENUE AND FORECASTS TO 2025 - COUNTRY ANALYSIS
13.1. MIDDLE EAST AND AFRICA (MEA) IMMUNOFLUORESCENCE ASSAY MARKET OVERVIEW
13.2. MIDDLE EAST AND AFRICA (MEA) IMMUNOFLUORESCENCE ASSAY MARKET REVENUE FORECASTS AND ANALYSIS (US$ MN)
13.3. MIDDLE EAST AND AFRICA (MEA) IMMUNOFLUORESCENCE ASSAY MARKET REVENUE AND FORECASTS ANALYSIS - BY TYPE (US$ MN)
13.4. MIDDLE EAST AND AFRICA (MEA) IMMUNOFLUORESCENCE ASSAY MARKET REVENUE AND FORECASTS ANALYSIS - BY PRODUCT (US$ MN)
13.5. MIDDLE EAST AND AFRICA (MEA) IMMUNOFLUORESCENCE ASSAY MARKET REVENUE AND FORECASTS ANALYSIS - BY DISEASE (US$ MN)
13.6. MIDDLE EAST AND AFRICA (MEA) IMMUNOFLUORESCENCE ASSAY MARKET REVENUE AND FORECASTS ANALYSIS - BY END USER (US$ MN)
13.7. MIDDLE EAST AND AFRICA (MEA) IMMUNOFLUORESCENCE ASSAY MARKET REVENUE AND FORECASTS ANALYSIS - BY COUNTRY (US$ MN)
13.8. SOUTH AFRICA MARKET OVERVIEW
13.8.1. South Africa Immunofluorescence Assay Market Revenue Forecasts and Analysis - By Type (US$ Mn)
13.8.2. South Africa Immunofluorescence Assay Market Revenue Forecasts and Analysis - By Product (US$ Mn)
13.8.3. South Africa Immunofluorescence Assay Market Revenue Forecasts and Analysis - By Disease (US$ Mn)
13.8.4. South Africa Immunofluorescence Assay Market Revenue Forecasts and Analysis - By End User (US$ Mn)
13.9. SAUDI ARABIA MARKET OVERVIEW
13.9.1. Saudi Arabia Immunofluorescence Assay Market Revenue Forecasts and Analysis - By Type (US$ Mn)
13.9.2. Saudi Arabia Immunofluorescence Assay Market Revenue Forecasts and Analysis - By Product (US$ Mn)
13.9.3. Saudi Arabia Immunofluorescence Assay Market Revenue Forecasts and Analysis - By Disease (US$ Mn)
13.9.4. Saudi Arabia Immunofluorescence Assay Market Revenue Forecasts and Analysis - By End User (US$ Mn)
13.10. UAE MARKET OVERVIEW
13.10.1. UAE Immunofluorescence Assay Market Revenue Forecasts and Analysis - By Type (US$ Mn)
13.10.2. UAE Immunofluorescence Assay Market Revenue Forecasts and Analysis - By Product (US$ Mn)
13.10.3. UAE Immunofluorescence Assay Market Revenue Forecasts and Analysis - By Disease (US$ Mn)
13.10.4. UAE Immunofluorescence Assay Market Revenue Forecasts and Analysis - By End User (US$ Mn)

14. SOUTH AND CENTRAL AMERICA IMMUNOFLUORESCENCE ASSAY MARKET REVENUE AND FORECASTS TO 2025 - COUNTRY ANALYSIS
14.1. SOUTH AND CENTRAL AMERICA IMMUNOFLUORESCENCE ASSAY MARKET OVERVIEW
14.2. SOUTH AND CENTRAL AMERICA IMMUNOFLUORESCENCE ASSAY MARKET REVENUE FORECASTS AND ANALYSIS (US$ MN)
14.3. SOUTH AND CENTRAL AMERICA IMMUNOFLUORESCENCE ASSAY MARKET REVENUE AND FORECASTS ANALYSIS - BY TYPE (US$ MN)
14.4. SOUTH AND CENTRAL AMERICA IMMUNOFLUORESCENCE ASSAY MARKET REVENUE AND FORECASTS ANALYSIS - BY PRODUCT (US$ MN)
14.5. SOUTH AND CENTRAL AMERICA IMMUNOFLUORESCENCE ASSAY MARKET REVENUE AND FORECASTS ANALYSIS - BY DISEASE (US$ MN)
14.6. SOUTH AND CENTRAL AMERICA IMMUNOFLUORESCENCE ASSAY MARKET REVENUE AND FORECASTS ANALYSIS - BY END USER (US$ MN)
14.7. SOUTH AND CENTRAL AMERICA IMMUNOFLUORESCENCE ASSAY MARKET REVENUE AND FORECASTS ANALYSIS - BY COUNTRY (US$ MN)
14.8. BRAZIL MARKET OVERVIEW
14.8.1. Brazil Immunofluorescence Assay Market Revenue Forecasts and Analysis - By Type (US$ Mn)
14.8.2. Brazil Immunofluorescence Assay Market Revenue Forecasts and Analysis - By Product (US$ Mn)
14.8.3. Brazil Immunofluorescence Assay Market Revenue Forecasts and Analysis - By Disease (US$ Mn)
14.8.4. Brazil Immunofluorescence Assay Market Revenue Forecasts and Analysis - By End User (US$ Mn)

15. INDUSTRY LANDSCAPE
15.1. ORGANIC GROWTH STRATEGIES
15.1.1. New Type Launches
15.1.2. Marketing & Promotional Activities
15.2. INORGANIC GROWTH STRATEGIES
15.2.1. Partnerships, Collaborations, and Joint Ventures
15.2.2. Mergers & Acquisitions

16. IMMUNOFLUORESCENCE ASSAY MARKET, KEY COMPANY PROFILES
16.1. THERMO FISHER SCIENTIFIC INC
16.1.1. Key Facts
16.1.2. Business Description
16.1.3. Financial Overview
16.1.4. Product Portfolio
16.1.5. Product Pipeline
16.1.6. SWOT Analysis
16.1.7. Key Developments
16.2. ABCAM PLC
16.2.1. Key Facts
16.2.2. Business Description
16.2.3. Financial Overview
16.2.4. Product Portfolio
16.2.5. Product Pipeline
16.2.6. SWOT Analysis
16.2.7. Key Developments
16.3. BIO-RAD LABORATORIES, INC.
16.3.1. Key Facts
16.3.2. Business Description
16.3.3. Financial Overview
16.3.4. Product Portfolio
16.3.5. Product Pipeline
16.3.6. SWOT Analysis
16.3.7. Key Developments
16.4. PERKINELMER INC
16.4.1. Key Facts
16.4.2. Business Description
16.4.3. Financial Overview
16.4.4. Product Portfolio
16.4.5. Product Pipeline
16.4.6. SWOT Analysis
16.4.7. Key Developments
16.5. MERCK KGAA
16.5.1. Key Facts
16.5.2. Business Description
16.5.3. Financial Overview
16.5.4. Product Portfolio
16.5.5. Product Pipeline
16.5.6. SWOT Analysis
16.5.7. Key Developments
16.6. BECTON DICKINSON AND COMPANY
16.6.1. Key Facts
16.6.2. Business Description
16.6.3. Financial Overview
16.6.4. Product Portfolio
16.6.5. Product Pipeline
16.6.6. SWOT Analysis
16.6.7. Key Developments
16.7. AGILENT TECHNOLOGIES,
16.7.1. Key Facts
16.7.2. Business Description
16.7.3. Financial Overview
16.7.4. Product Portfolio
16.7.5. Product Pipeline
16.7.6. SWOT Analysis
16.7.7. Key Developments
16.8. ENZO LIFE SCIENCES, INC
16.8.1. Key Facts
16.8.2. Business Description
16.8.3. Financial Overview
16.8.4. Product Portfolio
16.8.5. Product Pipeline
16.8.6. SWOT Analysis
16.8.7. Key Developments
16.9. SINO BIOLOGICAL INC.
16.9.1. Key Facts
16.9.2. Business Description
16.9.3. Financial Overview
16.9.4. Product Portfolio
16.9.5. Product Pipeline
16.9.6. SWOT Analysis
16.9.7. Key Developments
16.10. DANAHER
16.10.1. Key Facts
16.10.2. Business Description
16.10.3. Financial Overview
16.10.4. Product Portfolio
16.10.5. Product Pipeline
16.10.6. SWOT Analysis
16.10.7. Key Developments

17. APPENDIX
17.1. ABOUT THE INSIGHT PARTNERS
17.2. GLOSSARY OF TERMS
17.3. RESEARCH METHODOLOGY
The List of Companies

1. Thermo Fisher Scientific Inc.
2. Abcam PLC,
3. Bio-Rad Laboratories, Inc.
4. Perkinelmer Inc.
5. Merck KGaA
6. Becton Dickinson and Company
7. Agilent Technologies
8. Enzo Life Sciences, Inc.
9. Sino Biological Inc.
10. Danaher.

Select License Type
USD $4550
USD $6550
USD $8550

Free

20%

customization on Pre-Booking
Pre Book